The board of directors of CVS Health Corporation (NYSE:CVS) declared on Thursday its quarterly dividend of USD0.50 per share on its common stock.
This dividend is due on 1 November 2018 to shareholders of record as of 24 October 2018.
According to the pharmacy company, it enables people, businesses and communities to manage health in more affordable and effective ways through its integrated model.
Through retail locations and walk-in medical clinics, the pharmacy company serves 1m patients per year, with a stand-alone Medicare Part D prescription drug plan.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government